Considering high-dose EPA/DHA as a primary option for migraine preventionJanuary 20, 2024Headache & Migraine
Elevated odds of motor vehicle crashes in older adults after newly diagnosed migraineJanuary 20, 2024Headache & Migraine
Commentary: Examining CGRP Antagonists for Migraine Relief, January 2024December 23, 2023Headache & Migraine
Fremanezumab benefits migraine patients with inadequate response to prior preventive medicationsDecember 19, 2023Headache & Migraine
Galcanezumab and rimegepant offer effective options for prevention of episodic migraineDecember 19, 2023Headache & Migraine
Galcanezumab and rimegepant offer effective options for prevention of episodic migraineDecember 19, 2023Headache & Migraine
Comparative efficacy of anti-CGRP mAb in chronic and high-frequency episodic migraineDecember 19, 2023Headache & Migraine
Prior onabotulinumtoxin-A improves subsequent anti-CGRP mAb response in chronic migraineDecember 19, 2023Headache & Migraine
Galcanezumab effective for migraine prevention in women with menstrually related migraineDecember 19, 2023Headache & Migraine
Fremanezumab offers a safe and effective long-term treatment option for drug-resistant migraineDecember 19, 2023Headache & Migraine
Fremanezumab is effective and safe for migraine prevention under real-world conditionsDecember 19, 2023Headache & Migraine
